This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jul;47(1):160-2.

doi: 10.1016/j.jhep.2007.03.002. Epub 2007 Apr 12.

Pioglitazone: the beginning of a new era for NASH?

Lawrence Serfaty¹

Affiliations

Affiliation

¹ Hepatology Unit, Saint-Antoine Hospital, INSERM U680, Pierre&Marie Curie University, 184 rue du Faubourg Saint-Antoine, 75571 Paris Cedex 12, France. lawrence.serfaty@sat.aphp.fr

PMID: 17467111
DOI: 10.1016/j.jhep.2007.03.002

Comment

Pioglitazone: the beginning of a new era for NASH?

Lawrence Serfaty. J Hepatol. 2007 Jul.

. 2007 Jul;47(1):160-2.

doi: 10.1016/j.jhep.2007.03.002. Epub 2007 Apr 12.

Author

Lawrence Serfaty¹

Affiliation

¹ Hepatology Unit, Saint-Antoine Hospital, INSERM U680, Pierre&Marie Curie University, 184 rue du Faubourg Saint-Antoine, 75571 Paris Cedex 12, France. lawrence.serfaty@sat.aphp.fr

PMID: 17467111
DOI: 10.1016/j.jhep.2007.03.002

No abstract available

PubMed Disclaimer

Comment on

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. Belfort R, et al. N Engl J Med. 2006 Nov 30;355(22):2297-307. doi: 10.1056/NEJMoa060326. N Engl J Med. 2006. PMID: 17135584 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science